Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Element3 Health is a private digital health and healthcare services company focused on improving health outcomes for older adults by increasing their social, mental, and physical activity. The company works with Medicare Advantage and Medicare Supplement plans to administer benefits that cover dues and other costs associated with group activities such as clubs, associations, and community programs. Its underlying GroupWorks platform supports group activity management and benefit administration, and the business has increasingly been marketed under the name Grouper following a January 2024 rebrand. Rather than developing drugs, Element3 Health operates a tech-enabled services model aimed at reducing the health and cost burden associated with loneliness, inactivity, and social disconnection in aging populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Element3 Health.